Term ends Mar 23, 2029 · High confidence
20-year base term ends Mar 5, 2029
Held by Otsuka Pharmaceutical Co., Ltd.
Filed Aug 1, 2012 as application 13/564,479 · Granted Sep 24, 2013
Base term plus 18 days of patent term adjustment (USPTO delay)
Today
2009
2029
Clock starts
Mar 5, 2009
Mar 5, 2009
Term ends
Mar 23, 2029
Mar 23, 2029
Granted
Sep 24, 2013
Sep 24, 2013
base term
patent term adjustment
fee events
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
18
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
5
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 18 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Mar 5, 2009, when application 12/398,941, the earliest non-provisional in its chain, was filed (this one was filed Aug 1, 2012) | Mar 5, 2029 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +18 days, USPTO patent term adjustment record | Mar 23, 2029 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Mar 23, 2029 | High confidence |
This family
| US 8,258,962 | In force Nov 2030 | Nov 2030 |
| US 8,542,123 | this patent Mar 2029 | Mar 2029 |
| US 8,810,409 | Lapsed on the fee record Aug 2026 | Aug 2026 |
| US 9,060,708 | In force Mar 2029 | Mar 2029 |
| US 9,258,035 | In force Mar 2029 | Mar 2029 |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Oct 31, 2012 Reel 29221, frame 909 | Robertson, Timothy; Zdeblick, Mark | Proteus Biomedical, Inc. | Assignment of Assignor's Interest |
| Nov 2, 2012 Reel 29228, frame 436 | Proteus Biomedical, Inc. | Proteus Digital Health, Inc. | Change of Name |
| Feb 2, 2022 Reel 58868, frame 582 | Proteus Digital Health, Inc. | Otsuka America Pharmaceutical, Inc. | Assignment of Assignor's Interest |
| Feb 2, 2022 Reel 58868, frame 612 | Otsuka America Pharmaceutical, Inc. | Otsuka Pharmaceutical Co., Ltd. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Mar 2029
Term ends Mar 23, 2029. No further fees fall due before then
Note
The 18 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
29
later US patents cite this one
That is top 25% of utility patents granted in 2013 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.